Align Technology (NSDQ:ALGN) is tracking nearly 2 points higher today after posting 2nd-quarter figures that beat analysts’ expectations.
aligntechnology
ITC judge finds for Align Technology in overseas patent spat with ClearCorrect
Align Technology (NSDQ:ALGN) said a judge with the International Trade Commission found that Pakistani dental device maker ClearCorrect and a U.S. affiliate infringe 7 of Align’s patents.
Align sees some Wall Street love on strong Q1 earnings
Align Technology (NSDQ:ALGN) got a big Wall Street boost today after reporting a big increase in sales and strong growth in shipments of its flagship Invisalign product.
ResMed CEO Farrell hands corner office to his son | Personnel Moves
Align beats The Street and rises on record 2012 sales
Orthodontic devices maker Align Technology (NSDQ:ALGN) won big points on Wall Street today after releasing a strong 4th quarter earnings report, beating expectations and issuing optimistic projections for 2013.
Voices of 2012: A look at some of our best interviews of the year
"We play a critical role in managing and moving market share. I think the device sector has not necessarily acknowledged the role of the GPOs, but I think increasingly, as products mature in particular, GPOs play a vital role in helping to drive market share up on behalf of a supplier." — Novation CEO Jody Hatcher Photo gallery: MassDevice.com’s Big 100 Roundtable WestMassDevice held its 2nd annual Big 100 Roundtable West event in Newport Beach, Calif., December 11. A group of nearly med-tech executives and stakeholders gathered for an evening of networking, insight into medical device marketing and intimate interviews with David Pyott, CEO of Allergan; Tom Prescott, CEO of Align Technology; James Mazzo, president of Abbott Medical Optics; and Robert Grant, chairman and Strathspey Crown. MassDevice Big 100 Roundtable West 2012 Slideshow page 8 |